Precision Medicine in Action: Using Thyroid Cancer Biomarkers to Match the Right Patient with the Right Treatment at the Right Time

FACULTY

Lori Wirth, MD (Program Chair)
Medical Director
Massachusetts General Hospital’s Center for Head and Neck Cancers
Associate Professor
Harvard Medical School
Boston, Massachusetts

SPEAKING FACULTY

Shereen Ezzat, MD, FRCP(C), FACP
Professor of Medicine & Oncology
Endocrine Oncology
Princess Margaret Cancer Centre
University Health Network
Senior Scientist,
Ontario Cancer Institute
Toronto, Canada

Mark Zafereo, MD, FACS
Associate Professor,
Head and Neck Surgery
MD Anderson Cancer Center
Houston, Texas

Jaume Capdevila,MD, PhD
Attending Physician
Medical Oncology Department
Gastrointestinal and Endocrine Tumor Unit
Vall d’Hebron University Hospital
Vall Hebron Institute of Oncology
Barcelona, Spain

PROGRAM OVERVIEW

This live virtual activity will cover the diagnosis, treatment, and management of advanced thyroid cancer.


TARGET AUDIENCE

This educational activity is intended for oncologists and endocrinologists, as well as pathologists, along with their multidisciplinary teams in academic centers and the community setting who are especially challenged in keeping up with the most current data on new and emerging, less commonly occurring genomic alterations, genomic testing methodologies, and optimal treatment decisions for patients with thyroid cancer.


LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Utilize best practices for identifying actionable thyroid cancer molecular/genomic alterations in routine clinical practice.
  • Integrate available and emerging targeted treatment options into routine clinical practice for the treatment of patients with advanced thyroid cancer based on results showing actionable molecular/genomic alterations.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.


NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in caring for patients with advanced thyroid cancer.
Credit: 1.0 ANCC Contact Hour


CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.


DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.


DISCLOSURE OF CONFLICTS OF INTEREST

Faculty Relationship Manufacturer
Lori Wirth, MD Consultant Loxo Oncology, Eli Lilly, Merck, Bayer, BluePoint Laboratories, Cue Biopharma, and Eisai
Mark Zafereo, MD, FACS Research Funding Eli Lilly and Merck
Shereen Ezzat, MD, FRCP(C), FACP No relevant relationships with a manufacturer or commercial entity.
Jaume Capdevila, MD, PhD Speakers Bureau Ipsen, Pfizer, Novartis, Lilly, Exelixis, Merck Serono, Adacap, Eisai, Bayer, Sanofi
Consultant Ipsen, Pfizer, Novartis, Lilly, Exelixis, Merck Serono, Adacap, Eisai, Bayer, Sanofi

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
Dave Chatman, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Brianna Hanson, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.


DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.


METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this live virtual activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the live virtual activity.
  3. Submit the pre- and post-test and evaluation form to Med Learning Group.

You will receive your certificate as a downloadable file.


DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

RELEASE DATE: November xx, 2020

EXPIRATION DATE: November xx, 2021

Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.